YOUR BREAST CANCER RISK
IS MORE THAN YOUR FAMILY HISTORY
Introducing the premier home test kit for predictive risk and preventative healthcare.
Learn the likelihood of breast cancer over the next 5-years — and in your remaining life —
with a quick, easy-to-use cheek swab.
Understanding your genetic risk profile not only benefits you but also safeguards the health of the women you care about. Share this knowledge with your family to motivate them to get tested and lower their breast cancer risk.
Recently had a mammogram? Planning to schedule one soon? Our premier and cutting-edge collection kit is an easy way to take defensive measures into your own hands.
Fact: Women with dense breast tissue are at greater risk because tumors are harder to detect, even with a mammogram.
Fact: Research suggests dense breast tissue creates an environment where tumors have a greater chance at growing and spreading.
Fact: Up to 39% of breast cancer cases could potentially be prevented if women shifted from higher breast density categories (C and D) to lower categories (A and B).
Empower yourself to take a proactive approach to your health, giving you invaluable insights to protect yourself. Isn’t knowing the likelihood of a breast cancer diagnosis in your lifetime and a complimentary Genetic Counselor worth $149?
5 REASONS TO TAKE
OUR CANCER RISK ASSESSMENT TEST
PERSONALIZED INSIGHTS TO
PREVENT BREAST CANCER
As a woman over 30, your health is your top priority. geneType offers the most thorough breast cancer prediction test kit available today. Only geneType provides a detailed lifetime risk report and a free post-test consultation. This helps you and your doctor make a plan to keep you healthy.
ASSESS YOUR
UNIQUE GENETIC RISK
Our advanced analysis doesn’t just rely on family history like older tests do. Instead, we examine 300+ genetic markers to gauge your specific risk of breast cancer. This approach provides a more precise and useful understanding of your health status.
Predict. Prepare. Prevent.
Learn about your personal breast cancer risk profile and start a plan to ensure the best outcome. Focus on your wellbeing and feel empowered by knowing how to protect yourself in the future. Start your journey to a healthier tomorrow now!
EMPOWER
PROACTIVE CARE
Once you have your personalized risk score, you and your healthcare provider can team up to create customized screening and prevention plans. These might involve:
TRUSTED,
CLINICALLY VALIDATED
Our experienced team has devoted more than 20 years turning cutting-edge genetic research into reliable tests validated by science and modern-day reporting standards. We have 17 patents (and more pending) and our work is validated by other experts in the field. We’re dedicated to making personalized healthcare a reality because the “one-size-fits-all” model of yesterday isn’t guaranteed to work for everyone.
Don’t wait to put your health first. Start towards a longer, healthier life by ordering your geneType Breast Cancer Lifetime Risk Assessment Test today.
Unlike other tests that treat everyone the same, geneType is there for you even after you get your results. We offer a post-test session with one of our elite Genetic Counselors to explain your results and advise you on what to do next.
These sessions are included, at no extra cost, for both patients and healthcare providers. Our skilled Genetic Counselors are here to help you understand and support you with their valuable expertise.
With geneType, you’re never alone. We promise to assist you at every stage of your cancer prediction testing journey.
Don’t be afraid! Be the hero that defends against breast cancer with confidence.
See what the experts say:
Have a question about our geneType Breast Cancer Test or other services? Fill out the form below and our team will be in touch.
References
1. American Cancer Society. URL: https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html
2. van der Groep P et al. Cell Oncol (Dordr) 2011;34:71 -88.
3. Dite GS et al. Cancer Epidemiol Biomarkers Prev 2016;25:359 -65.
4. Allman R, et al. SNPs and breast cancer risk prediction for African American and Hispanic women. Breast Cancer Res Treat. 2015 Dec;154(3):583-9.
5. Spaeth E, et al. Validation of abridged breast cancer risk assessment model for the general population [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P2-10-06..
6. Medication Use to Reduce Risk of Breast Cancer, United States Preventative Services Task Force. JAMA. 2019; 322(9):857-867
7. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines); Breast Cancer Screening and Diagnosis. Version 1.2021- April 2022.
8. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines); Breast Cancer Risk Reduction. Version 1.2022 – April 2022
9. Use of Endocrine Therapy for Breast Cancer Risk Reduction. Journal of Clinical Oncology 37, no. 33 (November 20, 2019) 3152-3165.
10. Monticciolo D et al. Breast Cancer Screening Recommendations Inclusive of All Women at Average Risk: Update from the ACR and Society of Breast Imaging. J Am Coll Radiol. 2021 Sep;18(9):1280-1288.